A dad who thought he had a UTI was diagnosed with stage four bladder cancer and given 24 months to live. Dad-of-two Chris ...

Oncologists at AUA 2025 share promising data, including sasanlimab, cretostimogene grenadenorepvec, and TAR-200 in NMIBC.

Chris Cotton is raising money for cancer centers after being told the day after his 50th birthday that what he thought was a ...

TAR-200 demonstrated a high disease-free survival and bladder preservation rates in BCG-unresponsive, high-risk ...

Shares of Pfizer Inc (PFE) rose 0.6% in early premarket trading on Monday, tracking a three-week high, after the drugmaker ...

Aidixi plus BCG showed strong early efficacy and manageable safety in patients with high-risk, HER2-expressing ...

The targeted drug release device TAR-200 shows promising response and disease-free survival rates in specific populations of ...

A father initially mistook his symptoms for a UTI, only to receive a heart-shattering diagnosis of stage four bladder cancer ...

A 50-year-old UK father, mistook signs of bladder cancer for a UTI and kept drinking cranberry juice to treat the disease.

Two doses of a simple tuberculosis vaccination after surgery helps the immune system fight cancer cells and could greatly ...

LAS VEGAS -- Event-free survival (EFS) in high-risk non-muscle invasive bladder cancer (NMIBC) improved significantly when ...

Pfizer has reported positive results from a Phase III trial of sasanlimab and Bacillus Calmette-Guérin (BCG) for treating ...